🔖
Cite This Article
AFYON, M. (2022). Liver Biopsy is the Gold Standard at Present, How about Tomorrow?. Viral Hepatitis Journal, Cilt: 22 - Sayı: 2, 67–68. https://ajindex.com/articles/646409
Journals / Viral Hepatitis Journal / 2016 / Cilt: 22 - Sayı: 2
Liver Biopsy is the Gold Standard at Present, How about Tomorrow?
- Journal
- Viral Hepatitis Journal
- Pages
- 67–68
- Publication Date
- 2022-11-05
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (5)
- Kose S, Ersan G, Tatar B, Adar P, Sengel BE. Evaluation of Percutaneous Liver Biopsy Complications in Patients with Chronic Viral Hepatitis. Eurasian J Med 2015;47:161-164
- Stasi C, Milani S. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and costeffectiveness. World J Gastroenterol 2016;22:1711-1720
- Abdollahi M, Pouri A, Ghojazadeh M, Estakhri R, Somi M. Noninvasive serum fibrosis markers: A study in chronic hepatitis. Bioimpacts 2015;5:17-23
- Schmid P, Bregenzer A, Huber M, Rauch A, Jochum W, Müllhaupt B, Vernazza P, Opravil M, Weber R; Swiss HIV Cohort Study. Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy. PLoS One 2015;10:e0138838
- World Health Organization (WHO), Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. (Accessed April 2016) Available at: http://apps. who.int/iris/bitstream/10665/154590/1/9789241549059_eng. pdf?ua=1&ua=1